Ask the experts I

16.07.2024

EU HTA market access strategy panel

Remote, 16.07.2024

Strategically digested information

Do you need help or advice in understanding the new EU HTA framework? Do you have questions regarding the arising chances and risks for your business? Are you looking to expand your network and get in touch with strategic market access professionals?

Join our EU HTA expert discussions

Our panel of industry and market access professionals has the answers for you!

Apply now for free for our Q&A session on July, 16 at 5pm (CET).

Get in touch

Ihr Ansprechpartner Dr. rer. nat. Ingo Hantke

Dr. rer. nat. Ingo Hantke
Director Market Access
M.Sc. Life Science

Fon: +49 511 64 68 14 – 0
Fax: +49 511 64 68 14 18

E-Mail

Event

World Orphan Drug Congress 2024

22nd to 25th of Oct 2024

Fenja Lang

Meet SKC at booth 109!

Blog

Combination discount - a bureaucratic monster

Implementation regulation of the combination discount according to section 130e SGB V named by the BMG

Blog

Few therapies, a lot of research

Therapy options for paediatric dementia (neuronal ceroid lipofuscinosis)

Event

ISPOR Europe

17th to 20th of Nov 2024

Dr. rer. nat. Lydia Frick

Meet our experts at our booth 827.

Whitepaper

One HTA to assess them all 2.0 - The strategic perspective on EU HTA updated

EU HTA: European Health Technology Assessment (JCA)

Achieve planning security: With us you can align your projects and your resource planning comprehensively and at an early stage on EU HTA and its implications for market access.

to the top